Royce & Associates LP trimmed its holdings in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) by 19.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 116,375 shares of the semiconductor company’s stock after selling 28,333 shares during the quarter. Royce & Associates LP owned about 0.38% of Axcelis Technologies worth $9,350,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Close Asset Management Ltd purchased a new position in Axcelis Technologies during the third quarter worth about $27,000. Advisory Services Network LLC purchased a new position in Axcelis Technologies during the third quarter worth about $32,000. Caitlin John LLC purchased a new position in Axcelis Technologies during the third quarter worth about $32,000. EverSource Wealth Advisors LLC grew its position in Axcelis Technologies by 145.1% during the second quarter. EverSource Wealth Advisors LLC now owns 451 shares of the semiconductor company’s stock worth $31,000 after buying an additional 267 shares in the last quarter. Finally, Strs Ohio purchased a new position in Axcelis Technologies during the third quarter worth about $49,000. 89.98% of the stock is currently owned by hedge funds and other institutional investors.
Axcelis Technologies Trading Down 1.5%
Shares of ACLS stock opened at $155.55 on Friday. The stock has a market capitalization of $4.78 billion, a PE ratio of 48.46, a P/E/G ratio of 11.18 and a beta of 1.93. Axcelis Technologies, Inc. has a 1-year low of $55.93 and a 1-year high of $171.61. The business has a 50-day moving average of $127.05 and a 200 day moving average of $100.54. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.59 and a quick ratio of 2.99.
Insider Activity at Axcelis Technologies
In related news, VP Todd Sutton sold 2,000 shares of the stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $159.99, for a total transaction of $319,980.00. Following the completion of the sale, the vice president directly owned 6,360 shares in the company, valued at $1,017,536.40. This represents a 23.92% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Christopher Tatnall sold 1,166 shares of the stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $149.75, for a total value of $174,608.50. Following the completion of the sale, the executive vice president owned 27,627 shares of the company’s stock, valued at approximately $4,137,143.25. This trade represents a 4.05% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 34,453 shares of company stock worth $5,211,694 over the last three months. Corporate insiders own 0.49% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts recently commented on the company. B. Riley Financial upgraded Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 target price for the company in a research report on Monday, April 20th. Weiss Ratings cut Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Tuesday, May 12th. Finally, Zacks Research upgraded Axcelis Technologies from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Axcelis Technologies has an average rating of “Hold” and a consensus target price of $116.25.
View Our Latest Stock Report on Axcelis Technologies
Axcelis Technologies Profile
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
Featured Articles
- Five stocks we like better than Axcelis Technologies
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report).
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
